Iradimed (NASDAQ: IRMD) revenue
Iradimed reported revenue of $83.8m for fiscal 2025, 14.4% more than in fiscal 2024 ($73.2m). Since fiscal 2016 its revenue has grown by 157.9%, an average growth of 11.1% a year.
Iradimed has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2017, −29.0%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $83.8m | +14.4% | $26.1m | 31.2% |
| 2024 | $73.2m | +11.7% | $22.0m | 30.0% |
| 2023 | $65.6m | +23.0% | $20.0m | 30.6% |
| 2022 | $53.3m | +27.5% | $15.6m | 29.3% |
| 2021 | $41.8m | +31.8% | $9.8m | 23.5% |
| 2020 | $31.7m | −17.7% | −$0.8m | −2.4% |
| 2019 | $38.5m | +26.5% | $8.6m | 22.5% |
| 2018 | $30.4m | +31.9% | $6.0m | 19.7% |
| 2017 | $23.1m | −29.0% | $1.3m | 5.6% |
| 2016 | $32.5m | — | $10.9m | 33.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Iradimed revenue compared with its sector
By revenue for its latest fiscal year, Iradimed ranks 298th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Iradimed, 14.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 296th | ARS Pharmaceuticals | $84.3m | −5.5% |
| 297th | Nurix Therapeutics | $84.0m | 54.0% |
| 298th | Iradimed | $83.8m | 14.4% |
| 299th | Arcturus Therapeutics | $82.0m | −46.1% |
| 300th | MeiraGTx | $81.4m | 144.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Iradimed
- How much revenue did Iradimed make in fiscal 2025?
- Iradimed reported revenue of $83.8m for fiscal 2025, compared with $73.2m in fiscal 2024.
- How much has the revenue of Iradimed grown?
- Between fiscal 2016 and fiscal 2025 it went from $32.5m to $83.8m: 157.9% more, an average growth of 11.1% a year.
- What was the best year for revenue at Iradimed?
- Of its last 10 fiscal years, fiscal 2025, with $83.8m.
- Where does Iradimed rank in its sector by revenue?
- It ranks 298th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Iradimed come from?
- From the annual report (Form 10-K) that Iradimed files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Iradimed files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Iradimed: the Iradimed page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.